Gain-of-function type KIT mutations are observed in other malignancies, such as gastrointestinal stromal tumor (GIST), seminoma, and acute myelogenous leukemia (AML), though the mutated sites are varied among these malignancies [18]. This evidence concerns the gene KIT and acute myeloid leukemia.